Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six targeted therapeutic oncology candidates in clinical development.
Jun 4, 2013 at 9:30 AM ET
Merrimack Pharmaceuticals To Present at Jefferies 2013 Global Healthcare Conference